Ring Finger Protein 43 as a New Target for Cancer Immunotherapy

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

Protein Kinase D as a Potential New Target for Cancer Therapy

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2010English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2

Clinical Cancer Research
Cancer ResearchOncology
2015English

Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

NY-BR-1 Protein Expression in Breast Carcinoma: A Mammary Gland Differentiation Antigen as Target for Cancer Immunotherapy

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2007English

Melittin-Mil-2 Fusion Protein as a Candidate for Cancer Immunotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy

Genetics Research International
GeneticsMolecular Biology
2016English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy